GlassScriptPhysician profile
Matthew J Perry
NPI 1013996859
$41,573.80
in general payments reported to CMS, 2019-2025
37 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $29.94 · 2021: $131 · 2022: $8,146 · 2023: $2,116 · 2024: $14K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $18K · Travel and Lodging: $5,827 · Food and Beverage: $5,792 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Entertainment: $43.99 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $18,000.00 |
| Travel and Lodging | $5,827.42 |
| Food and Beverage | $5,792.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Entertainment | $43.99 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $37,462.67 | 2021-2025 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $638.36 | 2024-2025 | Aquabeam System |
| Janssen Biotech, INC. | $619.18 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Coloplast Corp | $484.47 | 2022-2025 | Titan, Speedicath |
| Boston Scientific Corporation | $260.64 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml, Rezum Generator |
| Abbvie INC. | $254.43 | 2022-2025 | |
| Astellas Pharma US INC | $209.72 | 2019-2024 | Xtandi |
| Novartis Pharmaceuticals Corporation | $152.18 | 2022-2025 | |
| Axonics, INC. | $152.03 | 2022-2023 | Axonics, Bulkamid |
| Urogen Pharma, INC. | $135.88 | 2022-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $122.35 | 2019-2022 | |
| Endo USA, INC. | $99.58 | 2024-2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $97.37 | 2019-2025 | Gentlecath |
| Conmed Corporation | $91.23 | 2025 | Airseal |
| Tolmar, INC. | $83.46 | 2024-2025 | Eligard |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $71.51 | 2023-2025 | Urolift, Barrigel |
| Laborie Medical Technologies Corp. | $70.89 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $63.53 | 2023-2025 | Gemtesa, Orgovyx |
| Olympus America INC. | $53.24 | 2019-2024 | Itind System |
| C. R. Bard, INC. & Subsidiaries | $46.24 | 2022 | |
| Edap Technomed INC | $43.99 | 2025 | |
| Dendreon Pharmaceuticals LLC | $39.69 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $38.11 | 2019 | |
| Pfizer INC. | $35.55 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $34.05 | 2025 | Adstiladrin |
| Allergan, INC. | $26.64 | 2019-2020 | |
| Zyla Life Sciences, INC. | $24.70 | 2019 | |
| Bluewind Medical | $19.63 | 2025 | |
| Immunitybio, INC. | $19.15 | 2025 | |
| Urovant Sciences INC | $18.53 | 2022 | |
| Novus Surgical Consultants | $17.13 | 2024 | |
| Angiodynamics, INC. | $16.99 | 2023 | Nanoknife |
| Antares Pharma, INC. | $16.59 | 2024 | Xyosted |
| Halozyme INC | $14.25 | 2023 | |
| Blue Earth Diagnostics | $13.92 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $13.24 | 2019 | |
| Baxter Healthcare | $12.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.